Updated Jul 16, 2026
Pinto Shelly has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $12K.

Shelly Pinto is the Interim CFO and Senior Vice President of Finance and Chief Accounting Officer at ALX Oncology Holdings Inc, a clinical-stage immuno-oncology company. She has been involved in the company's financial operations and has filed multiple SEC documents related to her roles.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | ALXO | ALX ONCOLOGY HOLDINGS INC | S — Open-market sale | 1.4K | $2.04 | $3K |
| 2026-03-23 | ALXO | ALX ONCOLOGY HOLDINGS INC | S — Open-market sale | 903 | $2.17 | $2K |
| 2026-02-20 | ALXO | ALX ONCOLOGY HOLDINGS INC | S — Open-market sale | 565 | $2.27 | $1K |
| 2026-01-07 | ALXO | ALX ONCOLOGY HOLDINGS INC | S — Open-market sale | 3.9K | $1.11 | $4K |
| 2025-08-15 | ALXO | ALX ONCOLOGY HOLDINGS INC | S — Open-market sale | 611 | $0.64 | $391 |
| 2025-07-07 | ALXO | ALX ONCOLOGY HOLDINGS INC | S — Open-market sale | 2.0K | $0.45 | $905 |
| 2025-06-30 | ALXO | ALX ONCOLOGY HOLDINGS INC | S — Open-market sale | 1.5K | $0.43 | $659 |
Shelly Pinto is the Interim CFO and Senior Vice President of Finance and Chief Accounting Officer at ALX Oncology Holdings Inc, a clinical-stage immuno-oncology company. She has been involved in the company's financial operations and has filed multiple SEC documents related to her roles.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 7 open-market sales ($12K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Pinto Shelly profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.